LYTIR

Insider · SEC Form 4 · Senior VP, Finance and PAO

Nemec Sarah

In the 12 months to Nov 8, 2026, on the open market: bought $2K of BOLT; sold $26K of BOLT. Filed a median of 2 business days after the trade.

Open-market purchases and sales this filer reported on SEC Form 4, by the day traded. Insiders have two business days to file. A sale marked 10b5-1 was made under a plan adopted in advance. How to read these

Insider purchases and sales, by month (last 12 months)Insider purchases: $2K in total; Insider sales: $26K in total.Jun: Insider purchases $2KSep: Insider sales $26KDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $2KInsider sales below: $26K
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.
  1. BOLTSold: Bolt Biotherapeutics, Inc. Sep 18, 2026 4,077 shares filed Sep 21, 2026 17,082 shares held directly after, as filed filing $13K
  2. BOLTSold: Bolt Biotherapeutics, Inc. Sep 17, 2026 2,922 shares filed Sep 21, 2026 21,159 shares held directly after, as filed filing $10K
  3. BOLTSold: Bolt Biotherapeutics, Inc. Sep 16, 2026 843 shares filed Sep 21, 2026 24,081 shares held directly after, as filed filing $3K
  4. BOLTBought: Bolt Biotherapeutics, Inc. Jun 5, 2026 509 shares filed Sep 21, 2026 1,924 shares held directly after, as filed filing $2K

Source: SEC Form 4 filings. Value is shares × the price reported on the filing; a filing whose price failed Lytir's check against the market price is left out, and a trade that related owners reported on separate forms is counted once. Filings can be late, amended or wrong at the source; see methodology.